Acrivon Therapeutics, Inc. (ACRV)
1.76
+0.04
(+2.33%)
USD |
NASDAQ |
Oct 15, 13:57
Acrivon Therapeutics Market Cap : 75.41M for Oct. 15, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 14, 2026 | 73.70M |
| October 13, 2026 | 74.98M |
| October 12, 2026 | 81.41M |
| October 09, 2026 | 81.84M |
| October 08, 2026 | 80.12M |
| October 07, 2026 | 80.55M |
| October 06, 2026 | 79.70M |
| October 05, 2026 | 84.84M |
| October 02, 2026 | 85.27M |
| October 01, 2026 | 86.12M |
| September 30, 2026 | 87.84M |
| September 29, 2026 | 89.12M |
| September 28, 2026 | 88.27M |
| September 25, 2026 | 89.98M |
| September 24, 2026 | 90.84M |
| September 23, 2026 | 88.27M |
| September 22, 2026 | 92.12M |
| September 21, 2026 | 86.12M |
| September 18, 2026 | 79.27M |
| September 17, 2026 | 72.84M |
| September 16, 2026 | 72.84M |
| September 15, 2026 | 78.41M |
| September 14, 2026 | 83.98M |
| September 11, 2026 | 85.69M |
| September 10, 2026 | 87.41M |
| Date | Value |
|---|---|
| September 09, 2026 | 85.27M |
| September 08, 2026 | 89.98M |
| September 04, 2026 | 91.26M |
| September 03, 2026 | 88.27M |
| September 02, 2026 | 92.12M |
| September 01, 2026 | 88.69M |
| August 31, 2026 | 89.55M |
| August 28, 2026 | 88.27M |
| August 27, 2026 | 92.12M |
| August 26, 2026 | 89.12M |
| August 25, 2026 | 93.41M |
| August 24, 2026 | 94.26M |
| August 21, 2026 | 94.69M |
| August 20, 2026 | 94.26M |
| August 19, 2026 | 102.40M |
| August 18, 2026 | 87.84M |
| August 17, 2026 | 87.84M |
| August 14, 2026 | 83.55M |
| August 13, 2026 | 79.27M |
| August 12, 2026 | 73.70M |
| August 11, 2026 | 74.13M |
| August 10, 2026 | 74.55M |
| August 07, 2026 | 67.03M |
| August 06, 2026 | 65.48M |
| August 05, 2026 | 63.54M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.386B |
| Alnylam Pharmaceuticals, Inc. | 31.09B |
| Anika Therapeutics, Inc. | 277.96M |
| Savara, Inc. | 979.76M |
| Vericel Corp. | 2.115B |
Market Cap Related Metrics
| Price to Book Value | 0.8702 |
| Price | 1.76 |
| Earnings Yield | -107.1% |